Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Italy: share of clinical trials for rare diseases 2013-2017

Share of authorized clinical trials to treat rare diseases in Italy from 2013 to 2017*

by Statista Research Department, last edited Aug 23, 2018
Italy: share of clinical trials for rare diseases 2013-2017 The statistic shows the share of authorized clinical trials to treat rare diseases in Italy from 2013 to 2017. According to data, the percentage of clinical trials related to rare diseases out of the total number of them authorized by the Italian Drug Agency, increased over the period considered, peaking at 25.5 percent as of 2017.
Show more

Share of authorized clinical trials to treat rare diseases in Italy from 2013 to 2017*

Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
I think of Statista as Google for researchers. Statista provides you with the information you search for right away.
Dr. Horst Stipp

Dr. Horst Stipp
EVP, Research & Innovation, Advertising Research Foundation

Statistics on "Clinical trials"
  • R&D overview
  • Top R&D companies
  • Clinical studies
  • Participation
  • Costs and market
  • Success rates
  • Approvals, launches, setbacks
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.